Article Versions Notes

Borkar S, Markus F, Oetting A, Schmidt S, Vössing C, Horst D, Möbs M, Braicu EI, Griesinger F, Horling K, et al. Detection of ESR1 Mutations in Tissue and Liquid Biopsy with Novel Next-Generation Sequencing and Digital Droplet PCR Assays: Insights from Multi-Center Real Life Data of Almost 6000 Patients. Cancers. 2025; 17(8):1266. https://doi.org/10.3390/cancers17081266

Borkar, Srushti, Fenja Markus, Agnes Oetting, Stefanie Schmidt, Christine Vössing, David Horst, Markus Möbs, Elena I. Braicu, Frank Griesinger, Katja Horling, and et al. 2025. "Detection of ESR1 Mutations in Tissue and Liquid Biopsy with Novel Next-Generation Sequencing and Digital Droplet PCR Assays: Insights from Multi-Center Real Life Data of Almost 6000 Patients" Cancers 17, no. 8: 1266. https://doi.org/10.3390/cancers17081266

Borkar, S., Markus, F., Oetting, A., Schmidt, S., Vössing, C., Horst, D., Möbs, M., Braicu, E. I., Griesinger, F., Horling, K., Tiemann, K., Heukamp, L. C., Willing, E.-M., & Vollbrecht, C. (2025). Detection of ESR1 Mutations in Tissue and Liquid Biopsy with Novel Next-Generation Sequencing and Digital Droplet PCR Assays: Insights from Multi-Center Real Life Data of Almost 6000 Patients. Cancers, 17(8), 1266. https://doi.org/10.3390/cancers17081266